Erin Dickerson
Family Health · Germantown, TNNPI 1013330141
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 456 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,108 and has fallen 52.3% since, to $1,481 in 2025.
Across 456 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- Amarin Pharma, Inc.$900
- Lilly USA, LLC$596
- AbbVie$575
- Abbott$559
- plus $3K from 27 others
What the payments were for
- Food & beverage$8,310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 90 | $1,783 |
| AstraZeneca | 48 | $1,018 |
| Amarin Pharma, Inc. | 51 | $900 |
| Lilly USA, LLC | 27 | $596 |
| AbbVie | 46 | $575 |
| Abbott | 15 | $559 |
| GSK | 37 | $445 |
| Boehringer Ingelheim | 12 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $232 |
| Pfizer | 8 | $221 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $205 |
| Merck | 14 | $202 |
| Kowa Pharmaceuticals America, Inc. | 8 | $181 |
| Amgen(2 entities) | 11 | $179 |
| Optinose US, Inc. | 10 | $126 |
| Biohaven Pharmaceuticals, Inc. | 11 | $126 |
| Bayer | 6 | $97 |
| Eisai Inc. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 7 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Esperion Therapeutics, Inc. | 4 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $52 |
| Corcept Therapeutics | 2 | $43 |
| Adlon Therapeutics L.p. | 2 | $42 |
| Johnson & Johnson | 3 | $37 |
| Exact Sciences | 2 | $30 |
| Genentech USA, Inc. | 3 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few family health providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 45 | $62,886 |
| OzempicSemaglutide | 23 | $40,663 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $38,119 |
| TrulicityDulaglutide | 18 | $31,639 |
| EliquisApixaban | 32 | $28,670 |
| FarxigaDapagliflozin Propanediol | 27 | $26,963 |
| LinzessLinaclotide | 23 | $25,087 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $18,128 |
| MyrbetriqMirabegron | 19 | $16,439 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $15,542 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $6,782 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 110 | $3,874 |
| SynthroidLevothyroxine Sodium | 22 | $2,285 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 64 | $2,037 |
| Atorvastatin Calcium | 161 | $1,682 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $596 | $94,52663 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $445 | $44,90163 claims |
| Novo NordiskOzempic | $1,783 | $40,66323 claims |
| MerckJanumet Xr, Janumet | $202 | $33,67023 claims |
| PfizerEliquis | $221 | $28,67032 claims |
| AbbVieLinzess, Synthroid | $575 | $27,37245 claims |
| AstraZenecaFarxiga | $1,018 | $26,96327 claims |
| Astellas Pharma US IncMyrbetriq | $20 | $16,43919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few family health providers in Tennesseeon file to place this against a meaningful peer group, so we don't.
Other family health in Germantown
- Donna HarrisGermantown$101
- Lindsay FrazierKnoxville$140K
- Jessica StanfillLexington$3K
- Evelyn WrightLawrenceburg$2K
- Honiko AbramsChattanooga$1K
- Carla FrankHixson$457
- Donna WinninghamCookeville$209
- Brooke TorbettMadisonville$44
- Carol CampbellNashville$23
- Mary JordanJasper$21
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.